Treatment and management plan on skin wounds
Skin wounds are sometimes challenging for healthcare providers to diagnose and treat as many have similar presentations. For advanced practice nurses, being able to identify various types of skin wounds, including whether a wound is colonization or an infection, is critical because it impacts recommended patient care. In your role, you must be able to evaluate skin wounds, determine the diagnosis, and develop an appropriate treatment and management plan according to current evidence-based guidelines.
To prepare:
- Review Chapter 47 of the Resnick text, as well as the Burr article in this week’s Learning Resources.
- Consider how to properly diagnose skin wounds in frail elders, including how to distinguish between colonization and infection.
- Select a type of skin wound, such as bumps, bruises, shingles, herpes, bullous pemphigoid, Stevens-Johnson syndrome, etc. Research the guidelines for treatment of the skin wound you selected. Reflect on how you would treat and/or dress this wound.
- Think about factors that might contribute to the development of the skin wound you selected. Consider strategies for the prevention and improvement of this type of wound.
To complete:
Write a 2- to 3-page paper that addresses the following:
- Explain how to properly diagnose skin wounds in frail elders, including how to distinguish between a colonization and infection.
- Describe the type of skin wound you selected.
- Explain how you would treat and/or dress this wound based on guidelines for treatment.
- Explain factors that might contribute to the development of the skin wound you selected. Include strategies for the prevention and improvement of this type of wound.
Skin Wounds
Student’s Name
University
Course
Professor
Date
Skin Wounds
Treatment and Management Plan on Skin Wounds
“From paper cuts to deep lacerations, skin wounds remind us of our body’s remarkable ability to heal and regenerate.” Skin wounds are a common occurrence that can happen to anyone at any time. They can be caused by various factors, such as accidents, burns, cuts, or surgical incisions (Tottoli et al., 2020). When a skin wound occurs, the body’s natural healing process is activated to repair the damaged tissue. The first stage of healing involves stopping bleeding and cleaning the wound. The next stage is inflammation, where the body sends white blood cells to fight off infection and remove damaged tissue. The final stage of healing is remodeling, where new tissue is formed to close the wound (Cañedo-Dorantes & Cañedo-Ayala, 2019). It’s essential to properly care for a skin wound to prevent infection and promote faster healing. In conclusion, skin wounds are a natural part of life, and with proper care, the healing process can be expedited to ensure a full recovery.
Skin wounds can vary in severity and require proper treatment and management to promote healing and prevent infection. The first step in creating a treatment and management plan is to assess the wound and determine the appropriate course of action (Atkin et al., 2019). This may involve cleaning the wound, applying dressings or bandages, and prescribing medications such as antibiotics or pain relievers. In addition, it is crucial to monitor the wound regularly and make adjustments to the plan as necessary to ensure that it is healing correctly. Ultimately, with proper treatment and management, most skin wounds can heal without complications and restore the affected area to its normal function and appearance. In this essay, the focus will be to explain how to properly diagnose skin wounds in frail elders, how to differentiate between colonization and infection, describe Stevens-Johnson syndrome as a type of skin wound, the treatment of Stevens-Johnson syndrome, and finally, look at the factors contributing to the development of Stevens-Johnson syndrome, and strategies for the prevention and improvement of Stevens-Johnson syndrome.
Diagnosing Skin Wounds in Frail Elders
As people age, their skin becomes thinner and more delicate, making wounding easier. Frail elders are at a higher risk of developing skin wounds due to their weakened immune systems and reduced mobility (Serra et al., 2018). Proper diagnosis of skin wounds is essential for prompt and effective treatment to prevent complications. Here are the steps to properly diagnose skin wounds in frail elders. The first step is visually inspecting the wound (Montgomery et al., 2018). The wound should be exposed and assessed for size, depth, and location. It is essential to note any signs of inflammation or infection, such as redness, warmth, or discharge. This visual examination will help determine the type of wound, whether it is a pressure ulcer, a venous ulcer, or a diabetic ulcer. The next step is to palpate the wound (Rupp et al., 2021). This involves gently touching the wound to assess its texture and tenderness. If the wound is painful or tender, it may indicate an underlying infection or inflammation. The surrounding skin should also be examined for signs of maceration, indicating prolonged moisture exposure.
The healthcare provider should also obtain a thorough medical history, including any underlying medical conditions, medications, and allergies. This information is crucial in determining the cause of the wound and identifying any potential complications. In addition, a culture of the wound may be taken to identify any bacterial or fungal infections (Metsemakers et al., 2018). This will help guide appropriate antibiotic therapy and ensure effective treatment. Finally, documentation of the wound’s location, size, and characteristics is essential (Masson‐Meyers et al., 2020). This documentation should include photographs, measurements, and descriptions of the wound’s color, depth, and odor. Regularly monitoring the wound is necessary to ensure it is healing correctly. Proper diagnosis of skin wounds in frail elders requires a thorough examination, medical history, and wound culture. Early and accurate diagnosis is crucial for prompt and effective treatment to prevent complications and promote healing.
Distinguish Between a Colonization and Infection
Colonization and infection are two terms often used interchangeably in microbiology, but they actually refer to different phenomena. In general, colonization refers to microorganisms on or within a host, whereas infection refers to the invasion and multiplication of microorganisms within a host that leads to disease (Pitocco et al., 2019). One of the critical differences between colonization and infection is the presence or absence of symptoms. In most cases, colonization does not result in noticeable signs or clinical manifestations (Sperlich et al., 2018). For example, it is common for healthy individuals to carry harmless bacteria, such as Staphylococcus aureus, in their noses or on their skin without experiencing any adverse effects. In contrast, infection is typically accompanied by various symptoms, such as fever, pain, inflammation, and tissue damage. These symptoms result from the body’s immune response to the invading microorganisms.
Another essential distinction between colonization and infection is the level of interaction between the microorganisms and the host. In colonization, the organisms may exist on the surface of the host without interacting with the underlying tissues or causing any harm. In some cases, colonization can be beneficial for the host. For example, certain bacteria in the gut can aid digestion and provide other health benefits. In contrast, the infection involves a more active interaction between the microorganisms and the host, with the organisms actively invading and multiplying within the host’s tissues and causing damage. Lastly, the diagnosis and treatment of colonization and infection also differ (Saunte et al., 2020). Colonization is often identified through routine microbiological testing, such as culturing samples from the affected area or using molecular methods to detect the presence of specific microorganisms. However, colonization treatment is usually unnecessary unless it poses a risk for disease transmission (Malinis et al., 2019). In contrast, the diagnosis of infection usually involves a clinical assessment of symptoms, along with laboratory testing to confirm the presence of microorganisms. Infection treatment typically consists of using antimicrobial agents to kill or control the growth of the invading organisms (Popović et al., 2019). While colonization and infection are related concepts in microbiology, they differ in their clinical manifestations, the level of interaction between the microorganisms and the host, and the diagnostic and treatment approaches used. Understanding these differences can help healthcare professionals make accurate diagnoses and appropriately treat their patients.
Stevens-Johnson Syndrome (SJS)
Stevens-Johnson syndrome (SJS) is a rare but serious skin and mucous membranes disorder. It is a severe condition called erythema multiforme, which causes the skin to become red and swollen (Kong et al., 2020). SJS typically begins with flu-like symptoms such as fever, sore throat, and cough. Painful red or purple blisters appear on the skin within a few days, and the affected areas may become raw and peel off in sheets. SJS can affect any body part, but it is most commonly found on the face, mouth, and genital area (Rashid et al., 2019). In addition to skin lesions, SJS can cause inflammation and blistering of the eyes, mouth, throat, and other mucous membranes. This can lead to difficulty eating, drinking, and speaking, and in severe cases, can cause vision loss. SJS is a serious medical emergency that requires immediate treatment. It is typically caused by an adverse reaction to medications, although infections or autoimmune disorders can also cause it. The most common medications that can trigger SJS include antibiotics, anti-inflammatory drugs, and anticonvulsants (Carrasquillo et al., 2019). The severity of SJS can vary from person to person, but it is a potentially life-threatening condition. Complications can include sepsis, organ failure, and pneumonia. Treatment usually involves hospitalization and supportive care, including fluid replacement, pain management, and treatment of any underlying infection or autoimmune disorder. Skin grafts may be necessary in severe cases to repair the damaged skin. Due to its rarity, there is no known way to prevent SJS. However, it is essential to be aware of the symptoms and seek medical attention immediately if they occur. Early diagnosis and treatment can help minimize the risk of complications and improve the chances of recovery.
The Treatment of Stevens-Johnson Syndrome
Stevens-Johnson Syndrome (SJS) is a severe and potentially life-threatening skin reaction that certain medications or infections can cause. Treatment for SJS is complex and typically requires hospitalization, as it can affect various parts of the body and requires specialized care. The first step in treating SJS is identifying and removing the causative agent (Barea‐Jiménez et al., 2020). This may involve discontinuing the medication that triggered the reaction or treating the underlying infection. In cases where the causative agent cannot be identified, supportive care is the mainstay of treatment. Supportive care for SJS includes managing pain, preventing infection, and maintaining fluid and electrolyte balance. Pain management may involve using analgesics such as acetaminophen or opioids (Pergolizzi. Et al., 2020). Patients with SJS may be given antibiotics or antiviral medications to prevent infection. Additionally, patients may require intravenous fluids and electrolytes to maintain hydration and avoid complications.
In severe cases of SJS, patients may require specialized care such as wound care, ophthalmologic care, or respiratory support. Wound care involves the management of blisters and other skin lesions to prevent infection and promote healing (Mirhaj et al., 2022). Ophthalmologic care may be necessary to manage eye complications such as conjunctivitis or corneal damage. Respiratory support may be required if the patient develops breathing difficulties due to the involvement of the respiratory tract. Overall, the treatment of SJS requires a multidisciplinary approach and close monitoring of the patient’s condition. If you suspect that you or someone you know is experiencing symptoms of SJS, it is essential to seek medical attention immediately. Early recognition and treatment of this condition can improve outcomes and reduce the risk of complications.
Factors that Might Contribute to the Development of Stevens-Johnson Syndrome
Stevens-Johnson Syndrome (SJS) is a rare and potentially life-threatening condition that can cause the skin and mucous membranes to blister, peel, and form painful sores. While the exact causes of SJS are not fully understood, several factors that may contribute to its development have been identified. One major factor is medication use (Mirhaj et al., 2022). SJS is often triggered by an adverse reaction to certain medications, particularly antibiotics, anticonvulsants, and non-steroidal anti-inflammatory drugs (NSAIDs). These drugs can stimulate an immune system response that causes the body to attack its tissues, leading to the characteristic skin and mucous membrane damage seen in SJS. Not everyone taking these medications will develop SJS, but those with a history of adverse drug reactions or certain genetic traits may be at a higher risk. Another factor that may contribute to SJS is infection (Zhang et al., 2020). Viral infections such as herpes and bacterial infections such as mycoplasma pneumonia have been linked to the development of SJS. In these cases, the body’s immune system may overreact to the pathogen’s presence, leading to skin damage and mucous membranes. In addition, certain genetic factors may play a role in the development of SJS. Studies have identified genetic variants associated with an increased risk of developing the condition. These variants may affect how the immune system responds to medication or infection, making some individuals more susceptible to SJS. Other factors contributing to SJS include environmental triggers, such as exposure to toxins or chemicals, and underlying medical conditions, such as systemic lupus erythematosus or HIV/AIDS (Cheng, 2021). In some cases, SJS may be idiopathic, meaning no apparent cause can be identified. Overall, the development of SJS is a complex process that likely involves genetic, environmental, and immunological factors. It is crucial for individuals at risk of developing SJS to be aware of the potential triggers and work closely with their healthcare providers to monitor and manage their condition.
Strategies for the Prevention and Improvement of Stevens-Johnson Syndrome
Stevens-Johnson Syndrome (SJS) is a rare and severe skin condition that can be life-threatening. The best strategy for preventing SJS is identifying and avoiding the triggers that may cause the illness (Lin et al., 2020). Some medications, such as antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants, have been linked to the development of SJS. Therefore, it is essential to avoid these medications, especially if you have a history of SJS or a family member who has had SJS. Another strategy for preventing SJS is to be aware of the symptoms and seek medical attention immediately if you experience any of them (White et al., 2018). Symptoms of SJS include fever, rash, and blisters on the skin, as well as pain and redness in the eyes. If you have any of these symptoms, you should seek medical attention immediately, as early treatment can improve your chances of recovery and reduce the risk of complications. Improving the management of SJS involves prompt recognition of the condition and early intervention. Treatment may include the discontinuation of any suspected medications, as well as the administration of intravenous fluids and pain medications (Yelehe‐Okouma et al., 2018). In severe cases, patients may require hospitalization in a burn or intensive care unit. In addition, after recovery from SJS, it is essential to avoid any medications or substances that may trigger the condition again. This may require working with a healthcare provider to identify alternative drugs or treatment options. Overall, prevention and improvement of SJS involve being aware of the risk factors and triggers for the condition, seeking prompt medical attention if symptoms occur, and working with healthcare providers to identify safe and effective treatment options.
Conclusion
In conclusion, skin wounds are a common problem among frail elders, and diagnosing and distinguishing between colonization and infection is essential. In severe cases like Stevens-Johnson Syndrome (SJS), proper treatment and management plans are crucial to prevent further damage and improve patient outcomes. Factors contributing to SJS must be considered to prevent its development, and strategies such as proper medication management and avoiding triggers can help reduce the risk. With a comprehensive approach to treatment and prevention, patients with skin wounds can receive the care they need to heal and thrive.
References
Atkin, L., Bućko, Z., Montero, E. C., Cutting, K., Moffatt, C., Probst, A., … & Tettelbach, W. (2019). Implementing TIMERS: the race against hard-to-heal wounds. Journal of wound care, 28(Sup3a), S1-S50. https://doi.org/10.12968/jowc.2019.28.Sup3a.S1
Barea‐Jiménez, N., Calero, J., Molina‐Negrón, D., & López Del‐Valle, L. M. (2020). Treatment for oral lesions in pediatric patients with Stevens‐Johnson’s syndrome: A case report and literature review. International Journal of Paediatric Dentistry, 30(4), 489-496. https://doi.org/10.1111/ipd.12615
Cañedo-Dorantes, L., & Cañedo-Ayala, M. (2019). Skin acute wound healing: a comprehensive review. International journal of inflammation, 2019. https://doi.org/10.1155/2019/3706315
Carrasquillo, O. Y., Santiago‐Vazquez, M., Cardona, R., Cruz‐Manzano, M., & Figueroa, L. D. (2019). Stevens‐Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. International Journal of Dermatology, 58(11), 1293-1299. https://doi.org/10.1111/ijd.14493
Cheng, L. (2021). Current pharmacogenetic perspective on Stevens-Johnson syndrome and toxic epidermal necrolysis. Frontiers in Pharmacology, 12, 588063. https://doi.org/10.3389/fphar.2021.588063
Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., … & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of infection and public health, 14(10), 1392-1394. https://doi.org/10.1016/j.jiph.2021.06.021
Lin, C. C., Chen, C. B., Wang, C. W., Hung, S. I., & Chung, W. H. (2020). Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies. Expert Review of Clinical Immunology, 16(4), 373-387. https://doi.org/10.1080/1744666X.2020.1740591
Malinis, M., Boucher, H. W., & AST Infectious Diseases Community of Practice. (2019). Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation, 33(9), e13548. https://doi.org/10.1111/ctr.13548
Masson‐Meyers, D. S., Andrade, T. A., Caetano, G. F., Guimaraes, F. R., Leite, M. N., Leite, S. N., & Frade, M. A. C. (2020). Experimental models and methods for cutaneous wound healing assessment. International journal of experimental pathology, 101(1-2), 21-37. https://doi.org/10.1111/iep.12346
Metsemakers, W. J., Morgenstern, M., McNally, M. A., Moriarty, T. F., McFadyen, I., Scarborough, M., … & Verhofstad, M. H. J. (2018). Fracture-related infection: a consensus on definition from an international expert group. Injury, 49(3), 505-510. https://doi.org/10.1016/j.injury.2017.08.040
Mirhaj, M., Labbaf, S., Tavakoli, M., & Seifalian, A. M. (2022). Emerging treatment strategies in wound care. International Wound Journal, 19(7), 1934-1954. https://doi.org/10.1111/iwj.13786 https://doi.org/10.1111/pai.13485
Montgomery, C., Blackburn, J., Withers, D., Tierney, G., Moran, C., & Simms, C. (2018). Mechanisms of ACL injury in professional rugby union: a systematic video analysis of 36 cases. British Journal of Sports Medicine, 52(15), 994-1001. http://dx.doi.org/10.1136/bjsports-2016-096425
Pergolizzi Jr, J. V., Magnusson, P., Raffa, R. B., LeQuang, J. A., & Coluzzi, F. (2020). Developments in combined analgesic regimens for improved safety in postoperative pain management. Expert Review of Neurotherapeutics, 20(9), 981-990. https://doi.org/10.1080/14737175.2020.1806058
Pitocco, D., Spanu, T., Di Leo, M., Vitiello, R., Rizzi, A., Tartaglione, L., … & Sanguinetti, M. (2019). Diabetic foot infections: a comprehensive overview. European review for medical and pharmacological sciences, 23(2), 26-37. https://dx.doi.org/10.26355/eurrev_201904_17471
Popović, N., Djokić, J., Brdarić, E., Dinić, M., Terzić-Vidojević, A., Golić, N., & Veljović, K. (2019). The influence of heat-killed Enterococcus faecium BGPAS1-3 on the tight junction protein expression and immune function in differentiated Caco-2 cells infected with Listeria monocytogenes ATCC 19111. Frontiers in Microbiology, 10, 412. https://doi.org/10.3389/fmicb.2019.00412
Rashid, M., Kashyap, A., & Undela, K. (2019). Valproic acid and Stevens‐Johnson syndrome: a systematic review of descriptive studies. International Journal of Dermatology, 58(9), 1014-1022. https://doi.org/10.1111/ijd.14411
Rupp, R., Biering-Sørensen, F., Burns, S. P., Graves, D. E., Guest, J., Jones, L., … & Kirshblum, S. (2021). International standards for neurological classification of spinal cord injury: revised 2019. Topics in spinal cord injury rehabilitation, 27(2), 1-22. https://doi.org/10.46292/sci2702-1
Saunte, D. M., Gaitanis, G., & Hay, R. J. (2020). Malassezia-associated skin diseases, the use of diagnostics and treatment. Frontiers in cellular and infection microbiology, 10, 112. https://doi.org/10.3389/fcimb.2020.00112
Serra, R., Ielapi, N., Barbetta, A., & de Franciscis, S. (2018). Skin tears and risk factors assessment: a systematic review on evidence‐based medicine. International Wound Journal, 15(1), 38-42. https://doi.org/10.1111/iwj.12815
Sperlich, J. M., Grimbacher, B., Workman, S., Haque, T., Seneviratne, S. L., Burns, S. O., … & Lowe, D. M. (2018). Respiratory infections and antibiotic usage in common variable immunodeficiency. The Journal of Allergy and Clinical Immunology: In Practice, 6(1), 159-168. https://doi.org/10.1016/j.jaip.2017.05.024
Tottoli, E. M., Dorati, R., Genta, I., Chiesa, E., Pisani, S., & Conti, B. (2020). Skin wound healing process and new emerging technologies for skin wound care and regeneration. Pharmaceutics, 12(8), 735. https://doi.org/10.3390/pharmaceutics12080735
White, K. D., Abe, R., Ardern-Jones, M., Beachkofsky, T., Bouchard, C., Carleton, B., … & Phillips, E. J. (2018). SJS/TEN 2017: building multidisciplinary networks to drive science and translation. The Journal of Allergy and Clinical Immunology: In Practice, 6(1), 38-69. https://doi.org/10.1016/j.jaip.2017.11.023
Yelehe‐Okouma, M., Czmil‐Garon, J., Pape, E., Petitpain, N., & Gillet, P. (2018). Drug‐induced aseptic meningitis: a mini‐review. Fundamental & clinical pharmacology, 32(3), 252-260. https://doi.org/10.1111/fcp.12349
Zhang, D., Guo, R., Lei, L., Liu, H., Wang, Y., Wang, Y., … & Hu, J. (2020). COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. MedRxiv, 2020-03. https://doi.org/10.1101/2020.03.24.20042655
If you are having challenges with writing your nursing essay either because of lack of time or not knowing where to start, you can order your paper here